BridgeMD
New treatment option for Percutaneous Nephrolithotomy (PCNL)
Official title Hemodynamic Effects of Surgical Position in Prone vs. Supine Percutaneous Nephrolithotomy
ClinicalTrials.gov ID: NCT07138872
What this study is testing
- What it's testing
- This prospective, randomized controlled study evaluates the hemodynamic effects of prone and supine positions during percutaneous nephrolithotomy (PNL) for large kidney stones. Surgical position may influence intraoperative and postoperative hemodynamic stability.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- ASA physical status I-III
- Presence of renal calculi indicated for PNL
You likely can't join if
- Pregnancy
- Uncontrolled coagulopathy
- Previous renal surgery
- Severe cardiac, pulmonary, or neurological disease
- Preoperative urinary tract infection (non-sterile urine culture)
- Surgery duration \ 120 minutes
See the full eligibility criteria
- ASA physical status I-III
- Presence of renal calculi indicated for PNL
- Pregnancy
- Uncontrolled coagulopathy
- Previous renal surgery
- Severe cardiac, pulmonary, or neurological disease
- Preoperative urinary tract infection (non-sterile urine culture)
- Surgery duration \ 120 minutes
- Preoperative blood transfusion
- Multiple access tracts
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.